Provisions for post-trial care {30}
Participants who achieve two successive negative liquid media cultures, the first of which is at or before week 08, with no positives to follow by the week 16 visit, will not receive further standard of care TB-treatment (continuation phase) according to national guidelines to complete 6 months of treatment. Their planned post-treatment follow-up visits at week 18, week 26, week 38 and week 52 will serve to determine whether they have achieved lasting cure. Participants who do not fulfil these criteria will receive standard of care TB-treatment according to national guidelines until week 26 at a government health facility. These participants will be invited to return for a follow-up visit at week 52 to determine their well-being and treatment outcome.Clinical trial insurance is obtained to compensate participants in case participating in this study causes any harm.